| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |